ASHP updates policies, procedures for drug shortages

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email
The American Society of Health-System Pharmacists (ASHP) has released updated guidance on the management of drug shortages, which focuses on policies and procedures that help minimize the effects of drug shortages on the quality of care. “The current situation of drug shortages is one where the most basic products are in short supply,” stated lead author Erin R. Fox, PharmD, BCPS, FASHP, senior director, Drug Information and Support Services at the University of Utah Health. She noted that the most frustrating thing is the unpredictability of drug shortages. Therefore, with appropriate planning and execution, organizations can mitigate the effects of drug shortages.

The ASHP guideline focuses on patient safety considerations, factors that contribute to drug shortages, and how to appropriately plan for and communicate about the shortage. Drug shortages are a safety concern because a pharmacy must alter how a product is ordered, prepared, or dispensed, and clinicians must then prescribe unfamiliar alternatives. ASHP noted that several essential elements of infrastructure need to be in place before a shortage occurs, such as a drug shortage team, a resource allocation committee, and established processes for approving alternative therapies and addressing ethical considerations.

Fox discussed her experience with a recent shortage involving both lidocaine and bupivacaine.

“Both drugs are critically short right now and we had to change our practices in clinics and in some inpatient settings to allow flexibility for which strength to use. This change isn’t causing any clinical differences for our patients, but it did require significant changes to our electronic health record [i.e., about 20 hours of work] to allow our clinics to use either 0.5% or 1% lidocaine depending on what we have available at the time.”

FDA’s Drug Shortage website and database are updated daily with information from the manufacturers. Pharmacists and other health professionals can look up information on the website and FDA encourages manufacturers to provide as much information as possible about the shortage and the expected duration as well as which products remain available. The website can be accessed at www.accessdata.fda.gov/scripts/drugshortages/default.cfm, and any questions can be e-mailed to FDA at drugshortages@fda.hhs.gov

For the full article, please visit www.pharmacytoday.org for the October 2018 issue of Pharmacy Today.

More To Explore

What is The Rx Consultant?

The Rx Consultant is a subscription-based service that delivers practical updates & reviews covering all the top-selling drugs and common health conditions. All our publications focus on the facts busy front-line pharmacists and other health care practitioners need to stay current, and provide it a streamlined, easy reading style.

For 30 years The Rx Consultant has operated independent of the pharmaceutical industry and has no commercial bias.

Join thousands of healthcare providers who enjoy the following benefits every month.

1. Drug Therapy Updates & Reviews

The eLibrary contains over 30 streamlined updates on drug therapy for the most common diseases. New articles are added every month – it is a continually expanding resource.

2. Continuing Education

The eLibrary includes 50+ hours of Pharmacology CE from an ACPE approved provider at no additional charge. Each article provides at least 1.5 hours of Pharmacology CE. Subscribers can take their tests online, score them immediately, then print or save their credit statements. Pharmacology CE tests can also be mailed, faxed, or even phoned in to The Rx Consultant office, and credit statements will be delivered by mail or fax.

3. Unlimited Access to our Resource Library, with:

  • Healthcare News

    The eLibrary includes a news column covering the developments that matter most to nurse practitioners and other front-line providers. You get a headline, the bottom line, and how it’s likely to affect your practice in a few short lines, then it’s on to the next news item. The news briefs are also available in print monthly as Rx News Connection.
  • Patient Education Pages

    Patient Q&A to sharpen your skills in educating patients and answering common questions.
  • Charts & Tables

    At-a-glance updates on drugs, doses, common side effects & interactions
  • Quick Facts

    Key facts organized for fast access both online and on handy reference cards.
  • The Bottom Line

    Our members suggest the topics and each issue undergoes a rigorous three month peer reviewed process. Our CE is different because we accept no grants, advertising, or funding of any kind from drug manufacturers. With no financial ties, maintaining a bias-free publication is a straightforward process.

The Rx Consultant maintains a high standard for quality

And a rigorous system for content development that insures it. Every issue is written by an expert in the topic area, and then peer reviewed, fact-checked and edited to insure that the content is

  • Evidence-based
  • Non-Biased
  • Balanced
  • Timely
  • Accurate and
  • Useful for community practitioners

The Rx Consultant is completely independent of the pharmaceutical industry.

We accept no grants, advertising, or funding of any kind from drug manufacturers. With no financial ties, maintaining a bias-free publication is a straightforward process.